Vertex Pharmaceuticals EBIT Margin 2010-2024 | VRTX

Vertex Pharmaceuticals ebit margin for the quarter ending June 30, 2024 was -3.37%.

  • Vertex Pharmaceuticals average ebit margin for 2023 was 41.16%, a 9.42% decline from 2022.
  • Vertex Pharmaceuticals average ebit margin for 2022 was 45.44%, a 17.23% decline from 2021.
  • Vertex Pharmaceuticals average ebit margin for 2021 was 38.76%, a 4.95% increase from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Vertex Pharmaceuticals EBIT Margin 2010-2024 | VRTX

  • Vertex Pharmaceuticals average ebit margin for 2023 was 41.16%, a 9.42% decline from 2022.
  • Vertex Pharmaceuticals average ebit margin for 2022 was 45.44%, a 17.23% decline from 2021.
  • Vertex Pharmaceuticals average ebit margin for 2021 was 38.76%, a 4.95% increase from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues